Want to join the conversation?
$WBA's 4Q15 total sales for the Pharmaceutical Wholesale division were $5.8Bil. On a pro forma constant currency basis, sales increased 5% compared with the same period a year ago. GAAP operating income was $133MM, while adjusted operating income was $158MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.